Skip to main content
Log in

A premature proposal for new liver cancer seromarkers

  • Commentary
  • Published:
Tumor Biology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Colli A, Fraquelli M, Casazza G, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol. 2006;101(3):513–23.

    Article  CAS  PubMed  Google Scholar 

  2. Chang TS, Wu YC, Tung SY, et al. Alpha-fetoprotein measurement benefits hepatocellular carcinoma surveillance in patients with cirrhosis. Am J Gastroenterol. 2015;110(6):836–44. quiz 845.

    Article  CAS  PubMed  Google Scholar 

  3. Siripongsakun S, Wei SH, Lin S, et al. Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation. J Gastroenterol Hepatol. 2014;29(1):157–64.

    Article  CAS  PubMed  Google Scholar 

  4. Kudo A, Matsumura S, Ban D, et al. Does the preoperative alpha-fetoprotein predict the recurrence and mortality after hepatectomy for hepatocellular carcinoma without macrovascular invasion in patients with normal liver function? Hepatol Res. 2014;44(14):E437–46.

    Article  CAS  PubMed  Google Scholar 

  5. Abdel-Hamid NM, Abouzied MM, Nazmy MH, Fawzy MA, Gerges AS. A suggested guiding panel of seromarkers for efficient discrimination between primary and secondary human hepatocarcinoma. Tumour Biol. 2015: [Epub ahead of print].

  6. Zhong JH, Ke Y, Gong WF, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg. 2014;260(2):329–40.

    Article  PubMed  Google Scholar 

  7. Zhong JH, Wu FX, Li H. Hepatic resection associated with good survival for selected patients with multinodular hepatocellular carcinoma. Tumour Biol. 2014;35(9):8355–8.

    Article  PubMed  Google Scholar 

  8. Zhong JH, You XM, Lu SD, et al. Historical comparison of overall survival after hepatic resection for patients with large and/or multinodular hepatocellular carcinoma. Med (Baltimore). 2015;94(35), e1426.

    Article  CAS  Google Scholar 

  9. Trevisani F, D’Intino PE, Morselli-Labate AM, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol. 2001;34(4):570–5.

    Article  CAS  PubMed  Google Scholar 

  10. Omata M, Lesmana LA, Tateishi R, et al. Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4(2):439–74.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kudo M, Izumi N, Kokudo N, et al. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis. 2011;29(3):339–64.

    Article  PubMed  Google Scholar 

  12. Li C, Zhang Z, Zhang P, Liu J. Diagnostic accuracy of des-gamma-carboxy prothrombin versus alpha-fetoprotein for hepatocellular carcinoma: a systematic review. Hepatol Res. 2014;44(10):E11–25.

    Article  CAS  PubMed  Google Scholar 

  13. Dai M, Chen X, Liu X, Peng Z, Meng J, Dai S. Diagnostic value of the combination of golgi protein 73 and alpha-fetoprotein in hepatocellular carcinoma: a meta-analysis. PLoS One. 2015;10(10):e0140067.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Zhou Y, Yin X, Ying J, Zhang B. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis. BMC Cancer. 2012;12:17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Jia Z, Wang L, Liu C, Yu Z, Chai L, Zhao M. Evaluation of alpha-fetoprotein-L3 and Golgi protein 73 detection in diagnosis of hepatocellular carcinoma. Contemp Oncol (Pozn). 2014;18(3):192–6.

    CAS  Google Scholar 

  16. Zhao Y, Wang M, Cui C, et al. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma. Cancer Biomark. 2015;15(5):677–83.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

This study was supported by projects from the Self-raised Scientific Research Fund of the Ministry of Health of Guangxi Province (nos. Z2015716, Z2015601, Z2015621, Z2014241).

Conflicts of interests

The authors declare that they have no conflicts of interest concerning this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jian-Hong Zhong.

Additional information

Liu-Cheng Wu and Wen-Feng Gong contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, LC., Gong, WF. & Zhong, JH. A premature proposal for new liver cancer seromarkers. Tumor Biol. 37, 4293–4294 (2016). https://doi.org/10.1007/s13277-016-4801-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-016-4801-z

Keywords

Navigation